Targeted taxane therapy for cancer.
Whelan
Jo
J
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage / Q000627:therapeutic use; D001952:Bridged-Ring Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D004281:Docosahexaenoic Acids; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D017239:Paclitaxel / Q000008:administration & dosage / Q000627:therapeutic use; D011099:Polyglutamic Acid; D011355:Prodrugs; D043823:Taxoids
D000970:Antineoplastic Agents; D000972:Antineoplastic Agents, Phytogenic; D001952:Bridged-Ring Compounds; D011355:Prodrugs; D043823:Taxoids; C080625:taxane; D004281:Docosahexaenoic Acids; D011099:Polyglutamic Acid; D017239:Paclitaxel